Skip to main content
Equibles

Legal & General Group Plc

Position in GLSI — Greenwich LifeSciences, Inc.

CIK 764068 London, X0
Back to GLSI Full portfolio

Position in GLSI

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$18,509
+$6,115 QoQ
Shares Held
789
+52.9% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#38
of 57 holders
Holding Since
Jun 2021
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GLSI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Legal & General Group Plc holds $3,299,239,490 across 292 Biotechnology names. GLSI ranks #248 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,870,015 $928,892,550
2 REGN
Regeneron Pharmaceuticals, Inc.
 759,971 $473,872,316
3 ALNY
Alnylam Pharmaceuticals, Inc.
 924,561 $278,320,596
4 RPRX
Royalty Pharma plc
 3,800,504 $213,094,258
5 INCY
Incyte Corp
 1,605,980 $182,053,892
6 ARGX
Argenx SE
 177,164 $164,367,443
7 INSM
INSMED Inc
 826,431 $88,114,072
8 RVMD
Revolution Medicines, Inc.
 381,366 $71,422,223

All Filings in GLSI

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $18,509 789
2026-03-31 $12,394 516
2025-12-31 $12,206 581
2025-09-30 $6,586 662
2025-06-30 $6,004 662
2025-03-31 $6,315 662
2024-12-31 $7,434 662
2024-09-30 $9,512 662
2024-06-30 $11,426 662
2022-03-31 $8,377 427
2021-12-31 $10,388 427
2021-09-30 $16,682 427
2021-06-30 $19,189 427